Kun-Long Hung | Personalized Medicine | Top Pharmaceutical Breakthrough Discovery Award

Published on by Top Pharmaceutical

Top Pharmaceutical Breakthrough Discovery Award

Kun-Long Hung
Fu Jen Catholic University Hospital, Taiwan

Kun-Long Hung
Affiliation Fu Jen Catholic University Hospital
Country Taiwan
Scopus ID 7202728402
Documents 81
Citations 1,862
h-index 23
Subject Area Personalized Medicine
Event International Top Pharmaceutical Awards

Kun-Long Hung is a Taiwanese clinician and researcher associated with Fu Jen Catholic University Hospital. His scholarly record demonstrates sustained contributions to personalized medicine, pediatric neurology, genetic disorders, developmental diseases, and translational healthcare research. According to Scopus metrics, his publication portfolio includes more than eighty indexed documents and a substantial citation impact within the medical research community.[1]

Abstract

This article summarizes the academic profile and scientific achievements of Kun-Long Hung. His research activities have focused on personalized medicine approaches, pediatric neurological disorders, genetic diagnostics, and evidence-based clinical practice. Through multidisciplinary collaborations, he has contributed to improved understanding of rare diseases and patient-centered healthcare strategies.[1]

Keywords

Personalized Medicine, Pediatric Neurology, Genetic Disorders, Clinical Research, Rare Diseases, Translational Medicine, Precision Healthcare, Developmental Disorders, Neurogenetics, Medical Innovation.

Introduction

The advancement of personalized medicine depends on researchers who integrate clinical observations with scientific investigation. Kun-Long Hung has participated in studies addressing neurological and genetic conditions affecting children and families. His published work reflects an ongoing commitment to improving diagnostic accuracy and therapeutic decision-making in modern healthcare environments.[2]

Research Profile

Based in Taiwan, Hung has established a recognized publication record supported by 81 indexed documents, 1,862 citations, and an h-index of 23. His research portfolio spans neurodevelopmental disorders, pediatric epilepsy, genetic syndromes, and precision medicine applications. These metrics indicate consistent scholarly engagement and meaningful influence across multiple areas of clinical medicine.[1]

Research Contributions

Hung has contributed to investigations involving developmental delay, neurofibromatosis, Dravet syndrome, tubulinopathy, and other neurological disorders. His work frequently combines genetic evaluation with clinical assessment to support individualized treatment planning. Such contributions align closely with contemporary precision medicine objectives and patient-focused healthcare models.[3]

Publications

Among his notable publications are studies on neurofibromatosis management in Taiwan, neurological manifestations of SARS-CoV-2 infection in children, developmental delay diagnostics, and rare genetic disorders. These publications demonstrate continued participation in clinically relevant research that addresses both local and international healthcare challenges while supporting evidence-based practice.[2]

Research Impact

The citation performance associated with Hung’s publications reflects engagement from researchers across medical and scientific disciplines. His studies have contributed to discussions involving diagnosis, disease management, and long-term outcomes in pediatric populations. This influence supports continued visibility within international biomedical literature and healthcare research communities.[1]

Award Suitability

The International Top Pharmaceutical Awards recognize researchers whose work advances healthcare innovation and scientific understanding. Hung’s contributions to personalized medicine, combined with his publication record and citation impact, align with the objectives of recognizing meaningful research achievements. His work illustrates the integration of clinical expertise and translational investigation.[4]

Conclusion

Kun-Long Hung has developed a substantial academic profile through research focused on pediatric neurology, genetic medicine, and individualized healthcare. His scientific contributions, publication metrics, and collaborative activities demonstrate continued involvement in advancing medical knowledge. These achievements provide a strong foundation for recognition within international research and healthcare award programs.

References

  1. Elsevier. (n.d.). Scopus Author Profile: Hung, K. L. (Author ID: 7202728402). Scopus. https://www.scopus.com/authid/detail.uri?authorId=7202728402
  2. Chu, Y. J., Wong, L. C., Ho, C. S., Lee, W. T., & Hung, K. L. (2024). Neurological manifestations of SARS-CoV-2 infection in children in Taiwan: A cross-sectional multicenter study. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2024.01.001
  3. Huang, C. S., Hung, P. L., Fan, P. C., Lee, W. T., & Hung, K. L. (2021). Clinical spectrum and comorbidities of Dravet syndrome in Taiwan and possible molecular mechanisms. Scientific Reports, 11, Article 15092. https://pubmed.ncbi.nlm.nih.gov/34642351/
  4. Hung, K. L., Lu, J. F., Su, D., Hsu, S., & Wong, L. C. (2022). Tubulinopathy presenting as developmental and epileptic encephalopathy. Children, 9(11), 1663. https://doi.org/10.3390/children9111663
  5. Liang, J. S., Hung, K. L., Lin, L., Keng, W. T., & Lu, J. F. (2023). Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature-sensitive characteristics. Epilepsy & Behavior, 147, 109387. https://doi.org/10.1016/j.yebeh.2023.109387

Olfa Trabelsi | Personalized Medicine | Women Researcher Award

Published on by Top Pharmaceutical

Women Researcher Award

Olfa Trabelsi
University of Technology of Compiègne, France

Olfa Trabelsi
Affiliation University of Technology of Compiègne
Country France
Scopus ID 36025990200
Documents 29
Citations 685
h-index 13
Subject Area Personalized Medicine
Event International Top Pharmaceutical Awards
ORCID 0000-0003-4415-8478

Olfa Trabelsi is a researcher affiliated with the University of Technology of Compiègne in France and is recognized for interdisciplinary research activities within biomedical engineering and personalized medicine. Her academic work combines computational mechanics with biological applications and demonstrates integration between engineering concepts and medical analysis. Bibliometric indicators and publication records indicate continuing contributions in tissue engineering and patient-specific modeling studies.[1]

Abstract

This article summarizes the academic profile and scientific contributions associated with Olfa Trabelsi. Research activities mainly involve computational biomechanics, tissue engineering applications, and biomedical modeling methodologies. Scientific outputs further indicate interdisciplinary collaborations designed to improve analytical approaches used in personalized medical systems and healthcare technologies.[2]

Keywords

Personalized Medicine, Biomedical Engineering, Biomechanics, Tissue Engineering, Computational Modeling, Medical Simulation, Patient-Specific Analysis.

Introduction

Current advances in healthcare increasingly rely on computational and patient-centered methodologies for diagnostic and therapeutic improvements. Olfa Trabelsi has participated in research environments involving biomedical analysis and engineering applications designed for clinical relevance. Such studies contribute toward the understanding of tissue behavior and individualized medical systems.[3]

Research Profile

According to ORCID records, Olfa Trabelsi currently serves as an Associate Professor at the University of Technology of Compiègne and has academic experience in biomechanics and computational mechanics research. Educational activities include doctoral studies in computational mechanics and multidisciplinary biomedical applications.[4]

Research Contributions

Research contributions include computational analysis of biological tissues, mechanical characterization studies, and predictive modeling techniques. Published investigations have focused on tracheal systems, vascular biomechanics, tissue remodeling processes, and personalized therapeutic assessment methods.[5]

Publications

Publication records demonstrate collaborative research across multiple biomedical disciplines and engineering frameworks. Scientific articles include computational bone remodeling studies, tissue engineering analysis, aneurysm prediction models, and tracheal mechanical simulations. Published works further illustrate integration between clinical requirements and engineering methodologies within patient-specific biomedical systems.

Research Impact

Citation statistics indicate measurable influence across scientific communities and interdisciplinary domains. The available bibliometric indicators suggest continuing relevance of published work and recognition through citations, collaborative outputs, and international dissemination activities.

Award Suitability

Academic metrics and scientific activities suggest alignment with criteria commonly associated with international research recognition programs. Contributions involving personalized medicine and biomedical technologies support consideration within broader scientific achievement categories.

Conclusion

Olfa Trabelsi represents an academic profile characterized by multidisciplinary investigation and continuing scientific activity. Research outputs demonstrate integration of engineering principles with healthcare technologies and support continuing development of personalized biomedical systems.

References

  1. Trabelsi, O., Duprey, A., Favre, J.P., & Avril, S. (2016). Predictive models with patient specific material properties for the biomechanical behavior of ascending thoracic aneurysms. Annals of Biomedical Engineering.
    https://doi.org/10.1007/s10439-015-1374-8
  2. Trabelsi, O., Davis, F.M., Rodriguez-Matas, J.F., Duprey, A., & Avril, S. (2015). Patient specific stress and rupture analysis of ascending thoracic aneurysms. Journal of Biomechanics.
    https://doi.org/10.1016/j.jbiomech.2015.04.035
  3. Trabelsi, O., et al. (2022). A simple and effective 1D-element discrete-based method for computational bone remodeling. Computer Methods in Biomechanics and Biomedical Engineering.
    https://doi.org/10.1080/10255842.2021.1943370
  4. Trabelsi, O., et al. (2020). In vitro histomechanical effects of enzymatic degradation in carotid arteries during inflation tests with pulsatile loading. Journal of Mechanical Behavior of Biomedical Materials.
    https://doi.org/10.1016/j.jmbbm.2019.103550
  5. Ruben, R.B., Carvalho, M., & Trabelsi, O. (2026). Biomechanics Analysis in Tissue Engineering. Bioengineering.
    https://doi.org/10.3390/bioengineering13060703

Jonathan Ejie | Personalized Medicine | Best Research Article Award

Published on by Top Pharmaceutical

Jonathan Ejie | Personalized Medicine | Best Research Article Award

Mr. Jonathan Ejie, UCSF, United States

Mr. Jonathan Ejie is an aspiring physician-scientist currently pursuing his M.D. at UCSF 🩺 (Class of 2026), following a B.S. in Electrical Engineering & Computer Science from UC Berkeley 💻. His research spans oncology, radiology, and AI in healthcare, with published work in Cancers (2025) and upcoming studies in Nature Communications 📊. Jonathan integrates data science 🧠 with clinical insights, contributing to health equity, quality improvement, and surgical education. A mentor, tutor, and award-winning leader 🏅, he co-founded the UCSF Futbol Club and serves underserved communities through advocacy and outreach.

Publication Profile 

Orcid

Education

Mr. Jonathan Ejie is an exceptional scholar whose educational journey bridges medicine and technology. He is currently pursuing his Doctor of Medicine (M.D.) degree at the prestigious University of California, San Francisco (UCSF) 🏥, with an expected graduation in 2026. Prior to this, he earned a Bachelor of Science in Electrical Engineering and Computer Science (EECS) 💻 from the University of California, Berkeley, graduating in 2022. His strong foundation in both engineering and clinical science equips him with a unique interdisciplinary perspective 🤖🩺, positioning him at the forefront of innovation in digital health and precision medicine.

Experience

Mr. Jonathan Ejie brings a blend of academic support and compassionate service to his professional journey. As an MCAT Physics Tutor at UCSF (2023), he guided 15+ students through complex physics concepts 📘⚛️. Earlier, at Contra Costa College (2019–2021), he tutored mathematics from Algebra to Calculus ➕📐. His volunteer work includes providing first aid at athletic events 🏃‍♂️🩹, teaching surgical skills to high school students at UCSF 🧵🧑‍⚕️, and serving as a Health Advocate at West County Health Center 💬🩺, helping underserved patients access vital community resources. His dedication reflects a strong commitment to both education and public health.

Awards

Mr. Jonathan Ejie has been recognized for his academic excellence and impactful contributions to medicine and research. In 2024, he was honored with the prestigious Sinkler Miller Medical Association Scholarship 🎖️, sponsored by Gilead, celebrating his commitment to health equity and academic distinction. He also received the UCSF School of Medicine Summer Explore Fellowship Grant 🌟, supporting his innovative pursuits in medical research. In May 2023, Jonathan earned the Inquiry Conference Travel and Dissemination Award ✈️📊, which enabled him to share his scholarly findings on a larger stage. These accolades reflect his rising potential and leadership in healthcare.

Research Focus 

Mr. Jonathan Ejie’s research focus lies at the intersection of oncology, health disparities, and medical data science. His standout work on the “Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer” 📉🩺 highlights critical inequities in healthcare delivery across race, geography, and insurance status. Combining his background in medicine 🧑‍⚕️ and computer science 💻, Jonathan leverages data analysis and machine learning 🤖📊 to drive systemic improvements in cancer care. His work reflects a commitment to equity, evidence-based medicine, and the pursuit of personalized, accessible treatment strategies for vulnerable cancer populations.

Publication Top Notes

  • Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer